Exchange Surveillance
- ASM Stage ILong Term Additional Surveillance Measure (LTASM) - Stage I
Price band ± 20%
Price
Trading Data
range barsReturns
absolute and vs benchmark indexAbout the Company
IOL Chemicals and Pharmaceuticals Ltd is a leading organic chemicals manufacturer and supplier in India. The company manufactures active pharmaceutical ingredient, organic chemicals and intermediates. The company was incorporated in the year 1986. The company manufactures and supplies industrial chemicals and bulk drugs for use in various pharmaceutical applications. Their portfolio includes industrial chemicals, industrial organic chemicals and bulk drugs. The company has two segments namely chemicals and pharmaceuticals. Under the chemical division, the company manufactures bulk chemicals, such as acetic acid and specialty chemicals, including ethyl acetate and acetic anhydride. Under pharmaceuticals division, the company manufactures active pharmaceutical ingredient, Ibuprofen. .The company also in the business activities of Drugs, Chemicals.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- HQ
- Barnala, Punjab
- Chairman
- Rajender Mohan Malla
- CEO & MD
- Varinder Gupta
- Registrar
- Alankit Assignment Ltd.
- Exchange
- NSE
- ISIN
- INE485C01029
Institutional Demand
passive ownership through ETFsContext
where this company sitsFrequently Asked
▶What is the share price of IOL Chemicals & Pharmaceuticals Ltd today?
IOL Chemicals & Pharmaceuticals Ltd (IOLCP) is trading at ₹164.14. The price shown is the latest available from the exchange feed and updates through the trading session.
▶What is IOLCP’s P/E ratio versus the sector?
IOLCP trades at a P/E of 33.8. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.
▶What is IOLCP’s dividend yield?
IOLCP has a dividend yield of 0.49%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.
▶What is IOLCP’s 52-week high and low?
IOLCP has traded between ₹67.19 and ₹224 over the past year. The Trading Data block shows where the current price sits inside that band.
▶What is the market capitalisation of IOL Chemicals & Pharmaceuticals Ltd?
IOL Chemicals & Pharmaceuticals Ltd has a market capitalisation of ₹5,963 crore.
▶What is IOLCP’s return on equity?
IOLCP reports a return on equity of 8.4%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Drug Manufacturers - Specialty & Generic.
▶Who are IOLCP’s competitors?
The Peers block on this page lists other Drug Manufacturers - Specialty & Generic companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.
▶What is IOLCP’s promoter holding?
Promoters hold 62.28% of IOLCP. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.
▶Which indices include IOLCP?
Index membership is listed in the Context block on this page, along with the weight IOLCP carries in each. That weight is what determines how much passive money tracks the stock.
▶Is IOL Chemicals & Pharmaceuticals Ltd a good buy?
We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from IOLCP’s own numbers. The judgement is yours.
IOLCP at a glance
IOL Chemicals & Pharmaceuticals Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector. IOL Chemicals & Pharmaceuticals Ltd (IOLCP) last traded at ₹164.14, giving it a market capitalisation of ₹5,963 crore. The 52-week range is ₹67.19 to ₹224, and the price is 62% of the way up that range. It trades at a price-to-earnings ratio of 33.8. Promoters hold 62.28% of the company in the latest shareholding filing.
| Market cap | ₹5,963 crore |
|---|---|
| P/E | 33.8 |
| ROE | 8.4% |
| ROCE | 11.3% |